Princeton to Import Novartis Vaccine for Meningitis Outbreak

Nov 16, 2013

Chicago Tribune

Despite the fact that Bexsero, a meningitis vaccine, is not approved for use in the United States, it will be imported to try to stop an outbreak of the disease at Princeton University, according to federal health officials. The vaccine already has been approved for use in Europe and Australia.

Bexsero, made by Swiss drugmaker Novartis, is designed to protect against a strain of the disease, serogroup B, that is not as common in the United States as it is in other parts of the world, says Barbara Reynolds, a spokeswoman for the Centers for Disease Control and Prevention. Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments